HB 2527 Pennsylvania House · 2021-2022 Regular Session

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.

Bill status signed all 5 stages cleared

Introduction

Apr 2022

Committee Review

Oct 2022

House Passage

Jun 2022

Senate Passage

Oct 2022

Signed into Law

Nov 2022

Introduced Apr 20, 2022 Signed Nov 3, 2022

Floor votes · Senate Oct 24, 2022 · House Jun 20, 2022

How they voted

45–0

Passed · 2 other

Total votes 47

Oct 24, 2022

D Democratic20

19 Yea 1

95% Yea

I Independent1

1 Yea

100% Yea

R Republican26

25 Yea 1

96% Yea

Vote distribution

All Yea All Nay Mixed No data

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Amendments

Nov 3, 2022

Signed into law

Approved by the Governor

upper

Oct 24, 2022

Upper · Passed

Third consideration and final passage

upper

Oct 24, 2022

Upper · Passed

Re-reported as committed

upper

Oct 18, 2022

Committee

Re-referred to APPROPRIATIONS

upper

Sep 20, 2022

Upper · Passed

Reported as committed

upper

Jun 21, 2022

Committee

Referred to JUDICIARY

upper

Jun 20, 2022

Lower · Passed

Third consideration and final passage

lower

Jun 20, 2022

Lower · Passed

Re-reported as committed

lower

Jun 15, 2022

Committee

Re-committed to APPROPRIATIONS

lower

May 24, 2022

Lower · Passed

PN 3150 Reported as amended

lower

Apr 20, 2022

Committee

PN 3004 Referred to JUDICIARY

lower

1 primary · 13 co-sponsors